baber/WOPTO huggingface dataset:
Patent IL-116474-A0 (IL)
Title: Clear concentrated liquid fabric softener compositions
IPC: D06M13/46
Filed: 1995-12-20
Abstract: Clear fabric softener microemulsion compositions have been developed for use in the rinse cycle comprising a combination of diester quaternary ammonium surfactants, diamido ammonium surfactants and selected organic solvents. Fatty co-softeners and oil perfumes may be included as optional ingredients. These microemulsions are converted to macroemulsions upon dilution with water in the rinse cycle to provide a fabric softening treatment.
Patent IL-117761-A0 (IL)
Title: Inhibitor of the erythrina caffra type and its use to purify serine proteases
IPC: C12N5/10
Filed: 1996-04-01
Abstract: A polypeptide which has the activity of an inhibitor DE-3 from Erythrina caffra and which reversibly and selectively binds serine proteases from a protein mixture is obtainable by culturing prokaryotic or eukaryotic host cells which have been transformed or transfected with a nucleic acid that codes for the said polypeptide in a manner that allows the host cells to express the said polypeptide under suitable nutrient conditions and isolating the said polypeptide, wherein the polypeptide has an amino acid sequence which is functionally analogous to SEQ ID NO:2, has a partial region that is more than 85% homologous to the region of amino acids 39-139 of this sequence, has two disulfide bridges and begins N-terminally with SEQ ID NO:4 or with a SEQ ID NO:4 extended N-terminally by methionine and has a binding capacity for tissue plasminogen activators of 1.25 MU/ml and more and is particularly suitable for purifying plasminogen activators such as tissue plasminogen activators (t-PA and derivatives).
Patent IL-128495-A0 (IL)
Title: Pharmaceutical compositions for treating sexual dysfunctions
IPC: C07D498/22
Filed: 1997-08-22
Abstract: A method for treating sexual dysfunctions is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-ÄN, N'-1,1'-((2"-ethoxy)-3'''(O)-4'''-(N,N-dimethylamino)-butane)-bis-(3,3 '-indolyl)Ü-1(H)-pyrrole-2,5-dione, particularly its hydrochloride, or mesylate salt.
Patent IL-137636-A0 (IL)
Title: Configuring method and device
IPC: H04L9/14
Filed: 1999-02-03
Abstract: A device for use in a receiver/decoder operable with different conditional access systems, the receiver/decoder including means for manipulating data received by the receiver/decoder according to a manipulation protocol which is configurable in dependence on the conditional access system, and means for storing parameters associated with the manipulation protocol, the device comprising:   means for receiving a command instructing configuration of the manipulation protocol in dependence on the conditional access system;   means for retrieving a parameter from the storing means in dependence on the command; and means for outputting said parameter to the manipulation means for use in configuring the manipulation protocol, whereby the manipulation means is not required to receive all parameters necessary to configure the manipulation protocol for all of the conditional access systems.   <IMAGE>
Patent IL-139974-A0 (IL)
Title: Culture medium for culture of animal cell and method for producing protein using same
IPC: C12N5/16
Filed: 1999-06-01
Abstract: A culture medium for culture of an animal cell, characterized by containing an enzymatic degradation product of fish meat or a fish meat extract, and a method for producing a desired protein with the use of the culture medium.
Patent IL-141131-A0 (IL)
Title: Communications system
IPC: H04B1/04
Filed: 1999-08-23
Abstract: A transmitter in a radiocommunications system such as a Wideband Code Division Multiple Access (WCDMA) communications system transmits one set of data on an in-phase (I-) channel and another set of data on a quadrature (Q-) channel. The transmitter generates a gain signal, ², and multiplies the digital data associated with the Q-channel by the gain signal, ². Complexity of the multiplication operation is reduced by limiting the gain signal, ², to a finite number of values that are exactly representable by a predefined number of bits, such as 4-bit values to the right of a binary radix point. Modulation inaccuracy associated with quantization of ² can be eliminated by utilizing the same quantized values of ² in all components within the radiocommunications system.
Patent IL-143337-A0 (IL)
Title: Component decoder and method thereof in mobile communication system
IPC: H04B7/26
Filed: 2000-10-05
Abstract: There is provided a decoder and a decoding method for decoding data modulated with a recursive systematic convolutional code (RSC) in a mobile communication system. In the decoder, a branch metric calculating circuit (BMC) calculates branch metrics (BMs) associated with a plurality of input symbols. An add-compare-select circuit (ACS) receives the BMs and previous path metrics (PMs) and generates an plurality of path selectors and LLR (Log Likelihood Ratio) data including the plurality of path selectors and reliability information at a first time instant. A maximum likelihood (ML) state searcher has a plurality of cells in an array with rows and columns, connected to one another according to an encoder trellis, cells in each row having a process time, Ds, for outputting the same value of the cells in the last column as an ML state value representing an ML path in response to the path selectors. A delay delays the LLR data received from the ACS by the time Ds. An LLR update circuit has a plurality of processing elements (PEs) in an array with rows and columns, connected according to the encoder trellis, PEs in each row having a process time, DL, for generating updated LLR values from the PEs at a time instant (first time instant-approximately DS+DL) in response to the delayed LLR data received from the delay. A selector selects one of the updated LLR values based on the ML state value.
Patent IL-144988-A0 (IL)
Title: Nasal delivery device
IPC: A61M3/02
Filed: 2000-03-03
Abstract: A nasal delivery device for delivering a substance to the nasal airway of a subject, comprising a delivery unit for delivering a gas flow and substance to one of the nostrils of the subject; wherein the delivery unit comprises a nosepiece which includes an outlet through which the gas flow and substance is in use delivered to the one nostril and a sealing member for providing a fluid tight seal between the outlet and the one nostril; wherein, during closure of the oropharyngeal velum of the subject, the delivery unit is configured to deliver the gas flow at a driving pressure to flow around the posterior margin of the nasal septum and out of the other nostril of the subject.
Patent IL-145005-A0 (IL)
Title: 4-OXO-4, 7-DIHYDRO-THIENO[2,3-b] PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS
IPC: A61K31/4365
Filed: 2000-03-07
Abstract: The invention provides a compound of formula I:wherein R1, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of preventing or treating a herpesvirus infection using such compounds or salts.
Patent IL-145814-A0 (IL)
Title: Synthetic methods for preparing procyanidin oligomers
IPC: C07D311/32
Filed: 2000-03-29
Abstract: Processes are disclosed for the production of linear and branched procyanidin oligomers having "n" procyanidin monomeric units where n is 2 to 18. The processes include coupling protected, activated monomers with an unprotected monomer to produce a partially protected (48) dimer. The dimer is optionally blocked, coupled with an activated protected monomer to produce a partially protected, optionally blocked trimer, and deprotected. The steps can be repeated to produce higher oligomers. Processes are also provided for producing (88), (86), and (66) dimers and doubly branched oligomers. Crystalline 8-bromo tetra- O- benzyl (-)-epicatechin is produced under certain conditions.
Patent IL-152685-A0 (IL)
Title: Hard coating coated parts
IPC: C23C30/00
Filed: 2002-11-07
Abstract: The invention refers to hard coating coated parts which are coated with a hard coating containing the elements Al, Ti, Cr, N, O with a chemical composition of each element of AlaTibCrcNwO100-w in the range of 30≤a≤70, 30≤b≤70, 0.5≤c≤20 a+b+c=100 at % and 70≤w≤99 %. The invention aims at a superior adhesion between the coating and the substrate without a reduction of the wear resistance, of the oxidation resistance and the friction properties, but improving every one of the coating properties to achieve a stable behavior under heavy-duty cutting resulting in a long life-time. Therefore, it is proposed that the full width at half maximum (FWHM) 2θ of the (200)x-ray diffraction peak is larger than 0.4 DEG and smaller than 0.7 DEG .
Patent IL-161287-A0 (IL)
Title: Free flowing melamine cyanurate agglomerate
IPC: C08K9/08
Filed: 2002-10-17
Abstract: The invention relates to agglomerates of flame-retardants, in particular melamine cyanurate, containing aggregates with an average size of between 0.1 and 10 wt. %, relative to the total agglomerates weight, and has a softening point higher than 40° C. The invention further relates to a method for producing said agglomerates, the use of the agglomerates in the preparation of polymer compositions, and polymer compositions containing melamine cyanurate.
Patent IL-165254-A0 (IL)
Title: Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
IPC: A61K31/40
Filed: 2003-05-16
Abstract: Methods of treating, preventing and/or managing cancer as well as diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Patent IL-165767-A0 (IL)
Title: Process for the preparation of dioxane acetic acidesters
IPC: C07B61/00
Filed: 2004-12-14
Abstract: Process for the preparation of an ester of formula (1), wherein R<1> represents a leaving group, CN, OH or a COOR<5> group, R<3> and R<4> each independently represent a 1-3 C alkyl group, and R<2> and R<6> each independently represent an ester group, wherein the corresponding salt with formula (2), wherein M represents H or an alkali (earth) metal in an inert solvent is contacted with an acid chloride forming agent to form the corresponding acid chloride, and the acid chloride is contacted with an alcohol with formula R<2>OH in the presence of N-methyl-morpholine. Preferably M represents an alkali metal, and R<2> represents an alkyl group, particularly a t.-butyl group. <CHEM> <CHEM>
Patent IL-169152-A0 (IL)
Title: Antibodies against pd-1 and uses therefor
IPC: C07K16/28
Filed: 2005-06-14
Abstract: This disclosure provides antibodies and antigen-binding fragments that can act as agonists and/or antagonists of PD-1 (Programmed Death 1), thereby modulating immune responses in general, and those mediated by TcR and CD28, in particular. The disclosed compositions and methods may be used for example, in treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer, and other immune system disorders.
Patent IL-183244-A0 (IL)
Title: Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
Filed: 2007-05-15
Abstract: A crystalline Form II of memantine hydrochloride, pharmaceutical compositions containing crystalline Form II, and methods of preparing crystalline Forms I and II of memantine hydrochloride are provided.
Patent IL-183481-A0 (IL)
Title: Antitumor combinations containing a vegf inhibitor and 5fu or one of its derivatives
Filed: 2007-05-28
Abstract: This invention relates to antitumor combinations comprising a VEGF inhibitor combined with 5-fluorouracil or with a 5-fluoropyrimidine derivative that are therapeutically useful in the treatment of neoplastic diseases, and pharmaceutical compositions comprising such combinations.
Patent IL-184080-A0 (IL)
Title: Synthesis of peptide t-20 using peptide intermediate fragments
Filed: 2007-06-20
Abstract: Methods for the solid phase synthesis of T-20 peptides and peptide intermediates, in particular methods involving synthesizing T-20 peptide intermediates at low loading factors to produce products having excellent purity and yield.
Patent IL-189666-A0 (IL)
Title: Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
Filed: 2008-02-21
Abstract: The present invention provides compounds of formula (I), or pharmaceutically acceptable salts or solvates thereof, methods for their preparation, methods for their use, and pharmaceutical formulations comprising them.
Patent IL-200129-A0 (IL)
Title: Regulatory t cell epitopes, compositions and uses thereof
Filed: 2009-07-28
Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant region. The invention also relates to methods of using and methods of making the epitopes of the invention.
Patent RO-126277-A0 (RO)
Title: Process for cultivating macromycetes of the species grifola frondosa and nourishing fungal biomass
Inventor: PETRE MARIAN
IPC: A61K36/06
Filed: 2010-11-03
Abstract: The invention relates to a biotechnological process for in vitro cultivation of macromycetes of the species Grifola frondosa to obtain a biomass with nourishing properties. According to the invention, the process provides for cultivation of macromycetes of the species Grifola frondosa in submerged condition, on a liquid nutritive medium, followed by transfer thereof into cultivation vessels, sterilization at 121°C for 15 min, cooling at temperatures of 25°C, aseptic inoculation with pure culture mycelium, incubation at a constant temperature of 23...25°C and a stirring rate of 100...200 rpm for 10...14 days, to obtain a biomass consisting of spherical mycelium formations which are separated from the liquid medium by centrifugation, are slowly dehydrated and conditioned as granules of 0.1...0.5 mm.
Patent RO-129463-A0 (RO)
Title: Process for repairing detached dislocations of road pavement
Inventor: ŢÎŢU AUREL MIHAIL
IPC: E01C23/00
Filed: 2013-11-11
Abstract: The invention relates to a technological process for operatively repairing the holes formed in bituminous road pavement. According to the invention, the process consists in changing the aleatory shape of the hole (), in two stages: a. excavation of a cavity () as a vertical deep bore in the shape of a truncated cone having the large base at the top, which reaches the road foundation () passing through the wearing layer (), the connecting layer () and the base layer (); b. priming the entire internal surface (), bottom of the cavity () included, with a current layer of bituminous binder, in order to provide film-like adherence, by friction, under the action of gravity and the motor vehicles weight, between the asphalt pavement mixture addition () and the internal walls (), followed by filling the cavity () with asphalt mixture ().
Patent RO-131045-A0 (RO)
Title: Process for functionalization of implants surface by using nanocompositions with complementary properties
Inventor: FLOROIAN LAURA
IPC: C23C16/515
Filed: 2015-12-08
Abstract: The invention relates to an implant structure, to a coating nanocomposite film and to a process for functionalization of implant surface, being meant to be used in the field of medicine. The implant structure, as claimed by the invention, comprises a thin film consisting of a mixture of bioactive glass, biocompatible polymer and a broad-spectrum antibiotic which is deposited by evaporation, using pulsed laser, onto a stainless steel substrate of the type 316L, with the following chemical composition, expressed in weight percentage: 0.013...0.030% C, 0.80...1.73% Mn, 0.3...0.7% Si, 0.019...0.036% P, 0.000...0.006% S, 16.50...17.65% Cr, 10.05...11.27% Ni, 2.00...2.39% Mo, 0.033...0.060% N, 0.21...0.44% Cu and 0.03...0.08% Co or another type of stainless steel. The film, as claimed by the invention, has the following composition: a. bioactive glass which may contain, in mass percentage, 56.5% SiO, 11% NaO, 3% KO, 15% CaO, 8.5% MgO, 6% PO, but also other percentage, b. a biocompatible polymer which may be polymethyl methacrylate or the like, and c. a broad-spectrum antibiotic which may be doxycycline, gentamicin, tetracycline or the like. The process, as claimed by the invention, takes place in an enclosure (1) of stainless steel provided with two vacuum pumps (2), a laser source (3), a cylindrical lens (4) made of MgFwith a focal lenght of 30 cm, for focusing the laser beam, and comprises the following steps: a. preparing the stainless steel substrate (5) by polishing and grinding with abrasive paper, immersing it in sodium hydroxide for 10...30 min at 75°C, treating it with oxalic acid at 85°C and cleaning it in an ultrasonic bath, b. preparing the deposition target (8) by mixing 0.4% bioactive glass, 3% polymer, 0.25% antibiotic, and 19.3 ml of solvent, the mixture being poured into a copper container and frozen at 77°K for 10 min, c. depositing the film with pulsed laser beam at a distance of 4 cm relative to the substrate.
Patent RO-137607-A0 (RO)
Title: Prefabricated panel for walls and facades of houses and buildings
Inventor: GHERMAN ION
IPC: E04B2/92
Filed: 2023-04-03
Abstract: The invention relates to a prefabricated panel for the walls and facades of houses and buildings. According to the invention, the panel consists of a rectangular metal frame (A) made of a single zinc-plated U-profile bar, partially cut into segments (1, 2, 3, 4, 5, 6 and 7) of different sizes, which are bent at 90° or 180° so that two of the long segments (1 and 4) and two of the short segments (2 and 3), equal in length, are placed base to base by bending, the frame long sides and short sides having equal dimensions in pairs where, after building the frame, a sheet (8) of flame-retardant polystyrene is placed inside it and a metal mesh (9) is placed over it, after which the metal frame is filled with a layer (10) of all-purpose adhesive and above the adhesive layer a second sheet (11) of extruded polystyrene with rabbets is arranged, which sheet is covered with a glass mesh (12), additionally screwed onto the metal frame (A) and finished with three layers (13) of adhesive for facades in which an aluminium angle-bar frame is fixed, and the last layer of the prefabricated panel consists of a decorative plaster (14) representing the outer surface of the prefabricated panel, while the frames of the closed or open corner panels are made of zinc-plated U-shaped profiles cut into segments bent at 90 and 180°, after which they are fixed to one another with screws, inside the frame there being arranged the sheet (8), the mesh (9), a layer (10) of adhesive, a second sheet (11), which is covered with mesh (12), additionally fixed with screws and finished with three layers (13) of adhesive, wherein a frame of aluminium angle-bar is fixed, and the last layer of the prefabricated corner panels consist of plaster (14) and the frames of the triangle prefabricated panels for gables are made of zinc-plated U-shaped profiles cut into segments which are bent at 90 and 135°, and 135 and 180°, respectively.
Patent MC-1795-A1 (MC)
Inventor: MM WERNER ASCHWANDEN
IPC: C07D221/10
Filed: 1987-01-22
Abstract: Benzazecine cpds of the formula (I) and benzoquinoline cpds of the formula (II) are new. R1 and R2 are each independently H or Cl; R3 is H, F, Cl, Br or OCH3; R4 is H, Cl or OCH3, and two or three of R1, R2, R3 and R4 are H; R5 is H, acetyl, propionyl, benzoyl, chloro benzoyl, methoxybenzoyl or phenylacetyl Also in (I) R5 may be a cleavable gp (Z) other than the acyl. - Eighteen cpds (I) including 4-acetyl-9-chloro-1,2,4,5,6,7 - hexahydro-4-benzazecine-3,8-dione and the corresp 4-acetyl-9,11-dichloro, 4-propionyl-11-chloro, 4-(p-methoxybenzoyl) -11-chloro, 9-chloro, 11-chloro-4-phenylacetyl and 4-acetyl-11-bromo cpds are specifically claimed.
Patent IE-910764-A1 (IE)
Title: Improvements in Barrier Seal Systems
Inventor: VOLDEN DOUGLAS J
IPC: F16J15/40
Filed: 1991-03-07
Abstract: This invention relates to barrier seal systems (10) for sealing the annular space between a housing (14) and a rotating shaft (12) which extends through a bore (16) in the housing (14). The seal system (10) has inboard (66) and outboard (46) mechanical end face seals. The inboard seal (66) faces have spiral grooves (98) for pumping a buffer fluid from a buffer chamber (68) between the two seals (46-66) toward the high pressure side of the inboard seal (66). The primary ring (76) of the inboard seal (66) may be double balanced. For high pressure applications, the buffer fluid may be pressurized and a pumping ring may be included in the outboard seal to circulate buffer fluid. High pressure applications also require two hard seal rings and optimum dam (100) and face widths. Buffer fluid can be supplied to the seal system by a reservoir (30) connected by a gravity feed line (108-112). A buffer fluid containment device may be attached to the high pressure side of the seal (10) to prevent process fluid from contaminating the seal faces or secondary seals.
Patent MA-27440-A1 (MA)
Title: Derives de pyrazole servant d'inhibiteurs du facteur de croissance transformant(tgf)
Inventor: BLUMBERG LAURA COOK
IPC: C07D471/04
Filed: 2005-03-18
Abstract: REVENDICATION DE PRIORITES US 18 Septembre 2002 60/412,146 US 2 Juillet 2003 60/484,543 Voir  en annexe le titre de l'invention et le texte de l'abrégé Dérivés de pyrazole servant d'inhibiteurs du facteur de croissance transformant (TGF) Des dérivés de pyrazole nouveaux de formule (Ia), des intermédiaires pour leur préparation, des compositions pharmaceutiques les contenant et leur utilisation en médecine sont décrits. Les composés de la présente invention sont de puissants inhibiteurs de la voie de transmission de signal du facteur de croissance transformant ("TGF")-(bêta). Ils sont utiles dans le traitement de divers états pathologiques en rapport avec le TGF, comprenant, par exemple, le cancer et des maladies fibrotiques.
Patent MA-52101-A1 (MA)
Title: Nouvelle technologie lfid « light frequency identification» et nlc « near light communication»
Inventor: BELHAF LAHSEN
IPC: H04B10/00
Filed: 2021-01-12
Abstract: La nouvelle invention consiste en l'utilisation de la lumière pour les communications entre une carte mémoire et ses lecteurs. La lumière peut êtrel'infrarouge, le rouge ou toute autre lumière. Les cartes vont contenir ; une puce mémoire qui va contenir le code d' identification et les autres données. Une électronique d' interface avec la mémoire, pour que tout fonctionne correctement. Une led pour l' émission des données de la carte vers le lecteur une photodiode ou unphototransistor pour recevoir les données du lecteur vers la carte une source d' énergie comme une pile, une cellule photovoltaïque ou toute autre source...
Patent MA-53773-A1 (MA)
Title: Dispositif portable pour l'enregistrement d'un électrocardiogramme
Inventor: ATBIR Ali
IPC: A61B5/00
Filed: 2021-07-16
Abstract: La présente invention concerne un dispositif portable (1) d'enregistrement de signaux électriques physiologiques d'un patient comprenant: une pluralité d'électrodes précordiales (3, 5, 7, 9, 11 , 13), chacune étant agencée pour être appliquée sur le thorax du patient pour l'acquisition d'un signal électrique physiologique, et un boilier portable (15), connecté à la pluralité d'électrodes précordiales, au sein duquel est ménagé un circuit de traitement et d'enregistrement des signaux électriques physiologiques acquis pour la génération de dérivations précordiales d'un électrocardiogramme. Les électrodes précordiales sont reliées les unes aux autres par une ou plusieurs liaisons extensibles .